Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred

2015 JAMA Neurology 162 citations

Abstract

This cross-sectional study provides additional information about the course of different AD biomarkers in the preclinical and clinical stages of autosomal dominant AD.

Keywords

PSEN1PrecuneusPositron emission tomographyPresenilinCerebrospinal fluidInternal medicineNeuroimagingMagnetic resonance imagingAlzheimer's diseaseMedicineBrain sizeBiomarkerStandardized uptake valueEndocrinologyOncologyHippocampal formationPathologyNeurosciencePsychologyDiseaseNuclear medicineBiologyRadiologyGenetics

Affiliated Institutions

Related Publications

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's dis...

2011 Alzheimer s & Dementia 9670 citations

Publication Info

Year
2015
Type
article
Volume
72
Issue
3
Pages
316-316
Citations
162
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

162
OpenAlex

Cite This

Adam Fleisher, Kewei Chen, Yakeel T. Quiroz et al. (2015). Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred. JAMA Neurology , 72 (3) , 316-316. https://doi.org/10.1001/jamaneurol.2014.3314

Identifiers

DOI
10.1001/jamaneurol.2014.3314